黑人MSM中PrEP研究HPTN 073的性传播感染发生率及相关因素
HPTN 073研究纳入226名HIV阴性的黑人男男性行为者,提供每日口服PrEP并进行12个月随访。基线STI患病率为14.2%,随访期间26.5%参与者发生至少1次STI,发病率为34.2例/100人年,且STI发生率与PrEP接受或依从性无关。
要点
- 基线STI患病率14.2%,<25岁者基线STI风险更高(25.3% vs 6.7%,OR 4.39)。
- 随访期间STI发病率为34.2例/100人年,26.5%参与者发生至少1次STI。
核心结论
- 该分析显示黑人MSM中PrEP使用者的STI发生率低于既往PrEP试验且未随时间增加,但年轻者及基线有STI者风险较高。
研究设计与样本
- HPTN 073研究为在美国3个城市招募226名HIV阴性黑人MSM的前瞻性队列,所有参与者接受客户中心关怀协调并每日口服PrEP,随访12个月。
主要发现
- 基线STI患病率为14.2%,<25岁男性基线STI患病率25.3%高于≥25岁的6.7%(OR 4.39,95%CI 1.91-10.11)。
- STI发生率与PrEP接受或依从性无关联。
临床怎么用
- 对开始PrEP的黑人MSM应筛查基线STI,尤其年轻者,并对基线有STI者加强针对性干预。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The HIV Prevention Trials Network (HPTN) Study 073 (HPTN 073) assessed the feasibility, acceptability, and safety of preexposure prophylaxis (PrEP) for black men who have sex with men (BMSM). The purpose of this analysis was to characterize the relationship between PrEP uptake and use and incident sexually transmitted infections (STIs) among participants enrolled in HPTN 073. METHODS: A total of 226 human immunodeficiency virus (HIV)-uninfected BMSM were enrolled in 3 US cities; all participants received client-centered care coordination (C4) and were offered daily oral PrEP. Participants were followed for 12 months with STI testing (rectal and urine nucleic acid amplification test for gonorrhea and chlamydia, rapid plasma reagin for syphilis) conducted at baseline, week 26, and week 52. Logistic regression was used to examine associations between STI incidence and PrEP uptake. Generalized estimating equations were used to evaluate associations between age, PrEP acceptance, sexual behaviors, and incident STIs. RESULTS: Baseline STI prevalence was 14.2%. Men aged <25 years were more likely to have a baseline STI (25.3% vs 6.7%; odds ratio [OR], 4.39; 95% confidence interval [CI:, 1.91, 10.11). Sixty participants (26.5%) acquired ≥1 STI during follow-up; the incidence rate was 34.2 cases per 100 person-years (95% CI, 27.4, 42.9). In adjusted analyses, baseline STI diagnosis (OR, 4.23; 95% CI, 1.82, 9.87; P < .001) and additional C4 time (OR, 1.03; 95% CI, 1.00, 1.06; P = .027) were associated with having an incident STI. STI incidence was not associated with PrEP acceptance or adherence. CONCLUSIONS: While we found higher rates of STIs in younger BMSM, overall rates of STI were lower than in prior PrEP trials, with no increase over time. BMSM with STIs at PrEP initiation may require additional interventions that target STI acquisition risk. CLINICAL TRIALS REGISTRATION: NCT01808352.
引用
- Hightow-Weidman LB, Magnus M, Beauchamp G, et al. Incidence and Correlates of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Participating in the HIV Prevention Trials Network 073 Preexposure Prophylaxis Study. Clin Infect Dis. 2019. PMID: 30615169. doi:10.1093/cid/ciy1141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。